<p>(A) WT mice were treated with T-0681 (36 nmol/kg/d) or PBS, and the treatment was continued during the 48-hours RCT study. 12 days into treatment, cholesterol-loaded, [<sup>3</sup>H]-labeled J774 macrophages were injected intraperitoneally, and 48 hours later tracer was measured in plasma, liver, and fecal sterols (N = 10). (B) Macrophage <i>in vivo</i> RCT in CETP Tg mice was performed as described in (A) (N = 5); inset: Western blot showing hepatic expression of LDLr and SR-BI; each lane represents pooled protein extracts from 5 mice per group. **<i>P</i><0.01, ***<i>P</i><0.001 versus corresponding control.</p
Background - Abundant data indicate that overexpression of apolipoprotein A-I (apoA-I) in mice inhib...
Objective—We previously reported that a systemic liver X receptor (LXR) agonist promoted macrophage ...
Background—Abundant data indicate that overexpression of apolipoprotein A-I (apoA-I) in mice inhibit...
<p>(A) Western blot showing expression of SR-BI in J774 macrophages treated with T-0681 at the indic...
<p>Chow-fed WT mice were treated with T-0681 (36 nmol/kg/d) or PBS. (A) Western blot showing hepatic...
<p>RAW 264.7 macrophages were labeled with [<sup>3</sup>H]cholesterol, loaded with AcLDL and transpl...
<p>(A) FPLC analysis of pooled plasma from SR-BI KO mice with and without T-0681 treatment (36 nmol/...
BACKGROUND: Liver-selective thyromimetics have been reported to efficiently reduce plasma choleste...
Background: Liver-selective thyromimetics have been reported to efficiently reduce plasma cholestero...
<p>C57BL/6 mice were treated with CsA as described in <a href="http://www.plosone.org/article/info:d...
Liver-selective thyromimetics have been reported to efficiently reduce plasma cholesterol through th...
Background—Cholesteryl ester transfer protein (CETP) transfers cholesteryl esters from high-density ...
Objective: Promoting reverse cholesterol transport (RCT) is a major atheroprotective property of HDL...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
BACKGROUND & AIMS: High-density lipoproteins (HDLs) protect against atherosclerotic cardiovascul...
Background - Abundant data indicate that overexpression of apolipoprotein A-I (apoA-I) in mice inhib...
Objective—We previously reported that a systemic liver X receptor (LXR) agonist promoted macrophage ...
Background—Abundant data indicate that overexpression of apolipoprotein A-I (apoA-I) in mice inhibit...
<p>(A) Western blot showing expression of SR-BI in J774 macrophages treated with T-0681 at the indic...
<p>Chow-fed WT mice were treated with T-0681 (36 nmol/kg/d) or PBS. (A) Western blot showing hepatic...
<p>RAW 264.7 macrophages were labeled with [<sup>3</sup>H]cholesterol, loaded with AcLDL and transpl...
<p>(A) FPLC analysis of pooled plasma from SR-BI KO mice with and without T-0681 treatment (36 nmol/...
BACKGROUND: Liver-selective thyromimetics have been reported to efficiently reduce plasma choleste...
Background: Liver-selective thyromimetics have been reported to efficiently reduce plasma cholestero...
<p>C57BL/6 mice were treated with CsA as described in <a href="http://www.plosone.org/article/info:d...
Liver-selective thyromimetics have been reported to efficiently reduce plasma cholesterol through th...
Background—Cholesteryl ester transfer protein (CETP) transfers cholesteryl esters from high-density ...
Objective: Promoting reverse cholesterol transport (RCT) is a major atheroprotective property of HDL...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
BACKGROUND & AIMS: High-density lipoproteins (HDLs) protect against atherosclerotic cardiovascul...
Background - Abundant data indicate that overexpression of apolipoprotein A-I (apoA-I) in mice inhib...
Objective—We previously reported that a systemic liver X receptor (LXR) agonist promoted macrophage ...
Background—Abundant data indicate that overexpression of apolipoprotein A-I (apoA-I) in mice inhibit...